Literature DB >> 18280224

Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study.

R Tomaiuolo1, F Sangiuolo, C Bombieri, A Bonizzato, G Cardillo, V Raia, M R D'Apice, M D Bettin, P F Pignatti, G Castaldo, G Novelli.   

Abstract

BACKGROUND: Mutation epidemiology in each ethnic group is a crucial step of strategies for cystic fibrosis (CF) diagnosis and counselling. To date, the scanning of the whole coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene permits to identify about 90% of alleles from patients bearing CF and a lower percentage in patients bearing atypical CF. CFTR rearrangements in heterozygosis elude current techniques for molecular analysis, and some of them have been reported with a frequency up to 6% in various ethnic groups.
METHODS: Using quantitative PCR analysis of all coding regions, we assessed the occurrence of CFTR rearrangements in 130 alleles from classic CF patients and in 198 alleles from atypical CF patients (all unrelated and from Italian descent) bearing unidentified mutations after the scanning of CFTR.
RESULTS: Seven rearrangements (i.e., dele1, dele2, dele2_3, dele 14b_17b, dele17a_18, dele22_23, and dele22_24) were identified in 34/131 (26.0%) CF alleles bearing undetected mutations (which means about 2.5% of all CF alleles) and in none of the 198 alleles from atypical CF. The CFTR haplotype and the sequence analysis of the breakpoints confirmed the common origin of all the rearrangements. Thus, we set up a novel duplex PCR assay for the large-scale analysis of the seven rearrangements. The procedure was rapid (all PCR amplifications were obtained under the same conditions), costless and repeatable.
CONCLUSIONS: It is useful to select the CFTR rearrangements more frequent in specific ethnic groups and to set up procedures for large-scale analysis. Their study can be performed in cases in which a high detection rate is required (i.e., partners of CF carriers/patients). On the contrary, the analysis of rearrangement is useless in atypical CF patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280224     DOI: 10.1016/j.jcf.2007.12.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  18 in total

1.  Notable contribution of large CFTR gene rearrangements to the diagnosis of cystic fibrosis in fetuses with bowel anomalies.

Authors:  Alix de Becdelièvre; Catherine Costa; Annick LeFloch; Marie Legendre; Jean-Marie Jouannic; Jacqueline Vigneron; Jean-Luc Bresson; Stéphanie Gobin; Josiane Martin; Michel Goossens; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

2.  When good CF tests go bad.

Authors:  Trudi McDevitt; David Barton
Journal:  Eur J Hum Genet       Date:  2008-12-03       Impact factor: 4.246

3.  Apparent homozygosity of a novel frame shift mutation in the CFTR gene because of a large deletion.

Authors:  Feras M Hantash; Arlene Rebuyon; Mei Peng; Joy B Redman; Weimin Sun; Charles M Strom
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

Review 4.  Congenital diarrheal disorders: an updated diagnostic approach.

Authors:  Gianluca Terrin; Rossella Tomaiuolo; Annalisa Passariello; Ausilia Elce; Felice Amato; Margherita Di Costanzo; Giuseppe Castaldo; Roberto Berni Canani
Journal:  Int J Mol Sci       Date:  2012-03-29       Impact factor: 6.208

Review 5.  Genetic diseases that predispose to early liver cirrhosis.

Authors:  Manuela Scorza; Ausilia Elce; Federica Zarrilli; Renato Liguori; Felice Amato; Giuseppe Castaldo
Journal:  Int J Hepatol       Date:  2014-07-14

6.  Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation Analysis.

Authors:  Adrien Pagin; Aurore Devos; Martin Figeac; Maryse Truant; Christelle Willoquaux; Franck Broly; Guy Lalau
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

7.  Molecular Analysis of Cystic Fibrosis Patients in Hungary - An Update to the Mutational Spectrum.

Authors:  Gergely Ivády; Katalin Koczok; Laszlo Madar; Eva Gombos; Izabella Toth; Klaudia Gyori; István Balogh
Journal:  J Med Biochem       Date:  2014-10-08       Impact factor: 3.402

8.  Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?

Authors:  Felice Amato; Manuela Seia; Sonia Giordano; Ausilia Elce; Federica Zarrilli; Giuseppe Castaldo; Rossella Tomaiuolo
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Apparent Homozygosity of p.Phe508del in CFTR due to a Large Gene Deletion of Exons 4-11.

Authors:  Vassos Neocleous; Panayiotis K Yiallouros; George A Tanteles; Constantina Costi; Maria Moutafi; Phivos Ioannou; Philippos C Patsalis; Carolina Sismani; Leonidas A Phylactou
Journal:  Case Rep Genet       Date:  2014-02-06

Review 10.  An update on laboratory diagnosis of liver inherited diseases.

Authors:  Federica Zarrilli; Ausilia Elce; Manuela Scorza; Sonia Giordano; Felice Amato; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.